Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
61 hedge funds and large institutions have $247M invested in Gritstone bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 13
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less funds holding
Funds holding: 63 → 61 (-2)
23% less capital invested
Capital invested by funds: $320M → $247M (-$73M)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$1.56M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$956K |
| 3 |
State Street
Boston,
Massachusetts
|
+$909K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$801K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$716K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$2.53M |
| 2 |
WCM
Wildcat Capital Management
New York
|
-$1.72M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.6M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.24M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$1.13M |
GRTS Hedge Fund Activity: Q3 2019 in Review
61 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q3 2019, worth a combined $247M — down 23% from $320M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of GRTS and 3 opened new positions — a net loss of 2 holders — while 13 trimmed existing stakes and 26 added.
The largest buyer was Northern Trust, adding an estimated $1.56M. The largest seller was Artal Group, cutting an estimated $2.53M.
- 61 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q3 2019, down from 63 in Q2 2019.
- Funds reported $247M of Gritstone bio, Inc. Common Stock stock for Q3 2019, down 23% quarter-over-quarter.
- 3 funds opened new Gritstone bio, Inc. Common Stock positions in Q3 2019 and 5 closed out, a net change of -2 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q3 2019 was Northern Trust, an estimated $1.56M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q3 2019 was Artal Group, an estimated $2.53M sold.
Based on aggregated 13F filings for Q3 2019.